Fatty acid-binding proteins in the diagnosis and disease severity prediction in pneumonia

Basit Öğe Kaydı
dc.authoridguven, ramazan/0000-0003-4129-8985
dc.contributor.authorCan, Doganay
dc.contributor.authorKalafat, Utku Murat
dc.contributor.authorDorter, Melis
dc.contributor.authorErdur, Ahmet
dc.contributor.authorBildik, Busra
dc.contributor.authorGuven, Ramazan
dc.contributor.authorDogan, Serkan
dc.date.accessioned2024-09-29T16:09:35Z
dc.date.available2024-09-29T16:09:35Z
dc.date.issued2022
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAim: Infections of the respiratory tract are important healthcare problems that are one of the main causes of referrals to the emergency department. PSI and CURB-65 are the most common scoring methods globally with proven accuracy and validity through many studies. Fatty acid-binding proteins are member of small cytoplasmic proteins that play a role in the transportation and deposition of lipids almost in all mammalian cells. They are strongly associated with metabolic and inflammatory processes. The aim of the present study was to determine the value of FABP for diagnosis and disease severity in patients diagnosed with pneumonia and to compare the correlation with PSI and CURB-65 scoring systems.Material and Methods: This prospective and single-cantered study was conducted on patients referring to the emergency department of Istanbul Kanuni Sultan Suleyman Training and Research Hospital who were diagnosed with pneumonia and on healthy volunteers. Results: FABP level was significantly higher in the patient group when compared with the control group (p: <0.01). FABP level was detected significantly higher in the severe pneumonia group of the binary groups created according to PSI and CURB-65 scoring. Discussion: As a result of the data obtained in the present study, it was concluded that FABP would be useful for the determination of the diagnosis, disease severity and the decision whether to hospitalize the patient with pneumonia. FABP is an important biomarker that guides the clinician for management of pneumonia patients who refer to the emergency department.en_US
dc.identifier.doi10.4328/ACAM.21223
dc.identifier.endpage1106en_US
dc.identifier.issn2667-663X
dc.identifier.issue10en_US
dc.identifier.startpage1103en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.21223
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7639
dc.identifier.volume13en_US
dc.identifier.wosWOS:000886534700009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPneumonia Inflammationen_US
dc.subjectInfection Biomarkeren_US
dc.subjectFABPen_US
dc.titleFatty acid-binding proteins in the diagnosis and disease severity prediction in pneumoniaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu